To view the PDF file, sign up for a MySharenet subscription.

MEDICLINIC INTERNATIONAL PLC - Notification of Major Interest in Mediclinic International plc shares

Release Date: 29/01/2019 15:30
Code(s): MEI     PDF:  
Wrap Text
Notification of Major Interest in Mediclinic International plc shares

Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
(“Mediclinic”, the “Company” or the “Group”)

29 January 2019

Notification of Major Interest in Mediclinic International plc shares

1a. Identity of the issuer or the underlying issuer                        Mediclinic International plc
of existing shares to which voting rights are at-
tached:
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)

Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights                                                           x
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify):

3. Details of person subject to the notification obligation
Name                                                         Mpilo Investment Holdings 2 (RF) (Pty) Ltd
City and country of registered office (if applicable)        Stellenbosch, South Africa

4. Full name of shareholder(s) (if different from 3.)
Name                                                         N/A
City and country of registered office (if applicable)

5. Date on which the threshold was crossed or                29/01/2019
reached:

6. Date on which issuer notified (DD/MM/YYYY):               29/01/2019

7. Total positions of person(s) subject to the notification obligation

                         % of voting rights at-   % of voting rights          Total of both in %   Total number of
                         tached to shares (to-    through financial instru-   (8.A + 8.B)          voting rights of is-
                         tal of 8. A)             ments                                            suer
                                                  (total of 8.B 1 + 8.B 2)
Resulting situation      0%                                                   0%                   737 243 810
on the date on which
threshold was
crossed or reached
                                                                                                                 
Position of previous     3.33%                                                3.33%
notification (if
applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or
reached

A: Voting rights attached to shares

Class/type of              Number of voting rights                        % of voting rights
shares
ISIN code (if possible)    Direct                Indirect                 Direct                  Indirect
                           (Art 9 of Directive   (Art 10 of Directive     (Art 9 of Directive     (Art 10 of Di-
                           2004/109/EC)          2004/109/EC)             2004/109/EC) (DTR5.1)   rective
                           (DTR5.1)              (DTR5.2.1)                                       2004/109/EC)
                                                                                                  (DTR5.2.1)
                           0                                              0%

SUBTOTAL 8. A              0                                              0%

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial in-      Expiration     Exercise/                     Number of voting rights   % of voting rights
strument                   date           Conversion Period             that may be acquired if
                                                                        the instrument is
                                                                        exercised/converted.

                                          SUBTOTAL 8. B 1               NIL                       NIL

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive
2004/109/EC (DTR5.3.1.1 (b))
Type of financial      Expiration         Exercise/           Physical or         Number of       % of voting rights
instrument             date               Conversion Pe-      cash                voting rights
                                          riod                settlement

                                                              SUBTOTAL            NIL             NIL
                                                              8.B.2
                                                                                                              
9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not
control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

Full chain of controlled undertakings through which the voting rights and/or the                                         X
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity
(please add additional rows as necessary)

Name                                          % of voting           % of voting rights         Total of both if it
                                              rights if it          through financial          equals or is higher
                                              equals or is          instruments if it          than the notifiable
                                              higher than the       equals or is higher        threshold
                                              notifiable            than the notifiable
                                              threshold             threshold
Phodiso Holdings Limited

Mpilo Investment Holdings 2 (RF) (Pty)        0%                                               0%
Ltd

10. In case of proxy voting, please identify:
Name of the proxy holder                                            N/A
The number and % of voting rights held                              N/A
The date until which the voting rights will be held                 N/A

11. Additional information
Mpilo Investment Holdings 2 RF (Pty) Ltd has been one of Mediclinic’s empowerment partners since 2005 and the
contractual arrangements of their investment expired on 31 December 2018.

Place of completion          Stellenbosch, South Africa
Date of completion           29/01/2019

Mediclinic has a primary listing on the Main Market of the LSE in the United Kingdom, with secondary listings on the
JSE in South Africa and the NSX in Namibia.

For further information, please contact:

Company Secretary, Link Company Matters Limited
Jayne Meacham / Caroline Emmet
+44 (0)20 7954 9569

Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
                                                                                                                       
+44 (0)20 3786 8181

Media queries
FTI Consulting
Brett Pollard/Debbie Scott – UK
+44 (0)20 3727 1000
Sherryn Schooling – South Africa
+27 (0)21 487 9000

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom
Website: www.mediclinic.com
Joint corporate brokers: Morgan Stanley & Co International plc and UBS Investment Bank
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
Date: 29/01/2019 03:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story